14-10-2025 16:06 Home | Feedback | Sitemap| Careers | Contact Us |FAQ | Investor Complaints Data | Investor Charter Stock-Broker | Investor DP
  You Are On: EQUITY
Equity Analysis
Price
Gainers & Losers
Out & Under Performers
Only Buyers & Sellers
Advances & Declines
New Highs & Lows
Weightage
5 Day's Up & Down
Historical Returns
Volume
Analysis
News Analysis
Corporate Action
Corporate Info
Other Market
Share Holdings
Piramal Pharma Ltd.
 
BSE Code 543635
ISIN Demat INE0DK501011
Book Value 56.48
NSE Code PPLPHARMA
Dividend Yield % 0.07
Market Cap 255415.03
P/E 35.51
EPS 5.41
Face Value 10  
Description ( As On June 2025 )No. of ShareHoldersNo. of Shares% of SharesDemat
Promoter          
  Indian Promoter  17  463324672  34.86  463324672  
  Foreign Promoter          
  Total Promoter  17  463324672  34.86  463324672  
          
Non Promoter          
 Institutions          
  Mutual Funds / UTI  25  163795423  12.32  163795423  
  FI/Bank/Insurance  16  22217776  1.67  22217776  
  Govt  3  4441    4441  
  FII          
  Other  196  413708352  31.12  413708352  
  Total Institutions  240  599725992  45.11  599725992  
 Non-Institution          
  Bodies Corporate  1330  16850466  1.27  16850466  
  Individuals          
  NRIs/OCBs  6562  14073182  1.06  14073182  
  Others  450281  235273818  17.7  235273818  
  Total Non-Institution  458173  266197466  20.03  266197466  
Total Non Promoter  458413  865923458  65.14  865923458  
          
  Depository Receipts          
          
Grand Total  458430  1329248130  100  1329248130  
 

Attention Investors : Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers / DP and Exchanges / Depository. Receive information of your transactions directly from Exchanges / Depository on your mobile/email at the end of the day .......... Issued in the interest of investors

KYC is one time exercise while dealing in securities markets – once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

“No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application from to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.’

Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.